|
Volumn 57, Issue 1, 2002, Pages 39-43
|
Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis
a
a
a
a
a
a
a
a
|
Author keywords
Levofloxacin; Long term; Multidrug resistant; Tuberculosis
|
Indexed keywords
AMIKACIN;
AMINOSALICYLIC ACID;
AMOXICILLIN PLUS CLAVULANIC ACID;
CAPREOMYCIN;
CIPROFLOXACIN;
CLOFAZIMINE;
CYCLOSERINE;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
KANAMYCIN;
LEVOFLOXACIN;
MOXIFLOXACIN;
OFLOXACIN;
PYRAZINAMIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFABUTIN;
RIFAMPICIN;
STREPTOMYCIN;
TERIZIDONE;
TUBERCULOSTATIC AGENT;
ADULT;
AGED;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL GROWTH;
BACTERIAL STRAIN;
BACTERIUM ISOLATE;
BLOOD EXAMINATION;
CARDIOVASCULAR DISEASE;
CASE REPORT;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GENE LIBRARY;
HUMAN;
HYPERURICEMIA;
IN VITRO STUDY;
INCIDENCE;
LIVER FUNCTION TEST;
LONG TERM CARE;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
MORTALITY;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM;
NONHUMAN;
PRIMARY HEALTH CARE;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
SECONDARY PREVENTION;
TENDON DISEASE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
EID: 14244270463
PISSN: 11220643
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (30)
|
References (22)
|